Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2020-10-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
第四届监事会第二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board regarding the approval of the company's 2020 third quarter report. It confirms the procedures and content of the quarterly report but does not contain the report itself or detailed financial data. The document length is short (702 characters) and serves as an official announcement of the meeting resolution and approval of the quarterly report. According to the rules, such announcements are not the report itself but rather a Regulatory Filing (RNS) or possibly a Report Publication Announcement (RPA). However, since it is a meeting resolution and not just a notice of report publication, it fits best under Regulatory Filings (RNS).
2020-10-29 Chinese
第四届董事会第二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's fourth board meeting, specifically approving the company's 2020 third quarter report. It states that the full third quarter report and its text have been disclosed on official information platforms. The document itself does not contain the financial data or substantive analysis of the quarterly report but rather announces the board's approval and the availability of the report elsewhere. The document length is short (867 characters), and it serves as a meeting resolution announcement rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the board meeting and report approval, not the Interim/Quarterly Report (IR) itself.
2020-10-29 Chinese
关于公司控股股东部分股份解除质押公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the release of pledged shares by the company's controlling shareholder. It details the number of shares released from pledge, the proportion of shares involved, and related shareholder information. There is no financial report, earnings data, or management discussion. The document is a regulatory announcement about share pledge status, which fits the category of Share Issue/Capital Change (SHA) as it relates to changes in share capital status (release of pledged shares). The document length is short and focused on this specific capital-related event, not a full report or earnings release.
2020-10-23 Chinese
关于公司控股股东部分股份解除质押公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the release of pledged shares by a controlling shareholder of the company. It details the number of shares released from pledge, the proportion of shares involved, and the absence of risks related to the pledged shares. It includes tables summarizing shareholding and pledge status. There is no financial performance data, no discussion of earnings, no management commentary, and no regulatory certification. The document is a specific disclosure about share pledge status, which fits best under the category of Regulatory Filings (RNS) as it is a regulatory announcement about share pledge changes and does not fit other more specific categories like Share Issue/Capital Change or Director's Dealing.
2020-10-20 Chinese
2020年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2020 first extraordinary general meeting (临时股东大会) of 葵花药业集团股份有限公司. It includes information about the meeting date, voting methods, attendance, detailed voting results on various proposals including amendments to company bylaws, election of board members and supervisors, and legal opinions on the meeting's validity. The document is not a report of financial results or management discussion, but an official disclosure of shareholder voting outcomes and meeting resolutions. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 7539 characters, which is substantive and contains detailed voting data, not just a brief announcement or a report publication notice. Therefore, the correct classification is DVA with high confidence.
2020-10-15 Chinese
2020年第一次临时股东大会的法律意见
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the convening, procedures, attendance, and voting results of a company's 2020 first extraordinary general meeting (临时股东大会). It details the legality and validity of the meeting's call, attendance, voting procedures, and results. The document includes detailed voting outcomes on various proposals, including amendments to company bylaws and election of board members. It is not a financial report, earnings release, or management discussion, but rather a formal legal opinion related to a shareholders' meeting. This type of document is best classified as a Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of a shareholders' meeting.
2020-10-15 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.